|
HHS Biomedical Advanced Research and Development Authority (BARDA) Radiological and Nuclear Threats Integrated Program Team
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
This Interagency Working Group, established under the Biomedical Advanced Research and Development Authority (BARDA), determines overall radiation countermeasures strategy and priorities. The National Institute of Allergy and Infectious Diseases (NIAID) provides subject matter expertise, advice and guidance on medical countermeasure development, requirements, and preparedness/response.
|
|
HHS Biovigilance Committee
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
CC, NHLBI
|
This committee develops systems for reporting adverse events resulting from blood transfusion or donation.
|
|
HHS Blood, Organ, and Tissue Senior Executive Council (BOTSEC)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, OS
|
NHLBI, CC
|
The HHS Blood, Organ, and Tissue Senior Executive Council (BOTSEC) is chaired by the Assistant Secretary for Health and voting members are the senior-most heads of the relevant Staff divisions and Operating divisions of HHS (e.g., the Director of CDC and NIH, Administrator of CMS, and Commissioner of FDA). The BOTSEC is an internal council chartered to consider significant issues and make decisions that require cross-Agency input, including resources. In important aspect of the BOTSEC is the formation of HHS-wide (i.e., multi-Agency) working groups to explore significant public health items such as re-examining the lifetime blood donor deferral policy for MSM, and the creation of hemovigilance systems to collect and analyze data on adverse events that occur during the blood donation and utilization processes.
|
|
HHS Climate Adaptation Strategies
|
Committee, Work group, Advisory group, or Task Force
|
CDC, OS
|
NIEHS
|
NIEHS has been partnering with the Assistant Secretary for Health (ASH), the Assistant Secretary for Administration (ASA), and more recently the Assistant Secretary for Preparedness and Response (ASPR) and other operating and staff divisions of HHS to respond to White House directives on climate change adaptation at the agency level. This includes production of the HHS Climate Adaptation Plan and the coordination and production of deliverables under the President''s Climate Action Plan.
|
|
HHS Climate Justice Conference
|
Meeting/ Workshop
|
CDC, IHS, OS
|
NIEHS, NIMHD
|
NIEHS co-hosted a, "HHS Climate Justice Conference" with the HHS Office of the Assistant Secretary for Health and other supporting organizations. The forum brought together researchers, policy makers, advocates, and implementers working in the fields of climate change and environmental justice. The meeting goal was to inform the implementation of the HHS Environmental Justice Strategy, create and implement meaningful public partnerships, and ensure interagency and intra-agency coordination.
|
|
HHS Dietary Guidance Review Committee
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, FDA, HRSA, IHS, OS
|
NIDDK
|
This committee reviews draft nutrition materials developed by all federal agencies and fulfills the legislative mandate (1990 NNMRRA) to ensure that Federal dietary guidance is consistent with the Dietary Guidelines for Americans and is scientifically accurate.
|
|
HHS ED Developmental and Behavioral Screening Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC
|
NICHD
|
This committee supports the objectives of improving developmental and behavior screening.
|
|
HHS Global Health Collaborative
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIMH
|
This interagency working group meets to provide a forum within the HHS that identifies Global Health issues relevant to the HHS Global mental health agenda.
|
|
HHS H5N1 Gain-of-Function Review Group (HHG Review Group)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, NIAID
|
The Framework for Guiding HHS Funding Decisions about Research Proposals with the Potential for Generating Highly Pathogenic Avian Influenza (HPAI) H5N1 Viruses that are Transmissible among Mammals by Respiratory Droplets requires that certain research proposals undergo additional review at both the funding agency and Departmental (HHS) levels prior to funding. The HHS Department-level review is performed by the HHG Review Group, which brings to bear multidisciplinary interagency expertise in science, countermeasure development and availability, national security, law, public health preparedness and response, biodefense, select agent regulations, and science and public health policy. The purpose of the HHS Department-level review includes review of the funding agency''s risk assessment, consideration of whether additional factors may alter assessment of whether the research can be funded, determination of which measures are needed to mitigate risks, consideration of the overall HHS influenza research portfolio, and determination of whether the proposal is acceptable for HHS funding.
|
|
HHS Initiative on Multiple Chronic Conditions
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, OS
|
OD/OSP, NIA, OD/DPCPSI/OBSSR
|
Recognizing the importance of Multiple Chronic Conditions (MCC) to patients, caregivers, and the health care system, the Assistant Secretary for Health convened an HHS-wide work group on MCC to identify options for improving the health of this population. The work group, in conjunction with other stakeholders, developed Multiple Chronic Conditions: A Strategic Framework. The Framework serves as a national-level roadmap for assisting HHS programs and public and private stakeholders to improve the health of individuals with MCC.
|